A revolution in lung cancer treatment is happening at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). Our research is proving that lung cancer is not solely defined by location and stage, but rather the individual molecules and genes that drive each patient’s unique cancer. Simply put, there is no routine lung cancer. To deliver the most effective ways to treat each unique lung cancer, world-renowned researchers and oncologists at the OSUCCC – James use their collective knowledge and expertise to understand each cancer at a genetic level, pinpoint what makes it grow and deliver treatments that target one particular lung cancer...yours. Next-generation genomic screening allows researchers and oncologists to rapidly and cost-effectively characterize cancer-related genes in ways that weren’t possible 10 years ago. “Genomic technology provides us with tools to better understand a patient’s cancer,” says Sameek Roychowdhury, MD, PhD, a medical oncologist and specialist in cancer genomics at the OSUCCC – James. Genomic-based medicine used in the OSUCCC – James lung cancer clinic enables oncologists to better diagnose a patient’s particular cancer; better determine the patient’s prognosis, or the risk that the cancer will return; and identify the best therapy or clinical trial for a patient based on the genetic changes in his or her tumor. “New lung-cancer patients at the OSUCCC – James are currently tested for mutations in 12 genes to help guide their therapy,” says lung-cancer specialist Gregory Otterson, MD. “Genomics in cancer care helps us identify the right treatment for the right patient.” By developing and delivering the most advanced and targeted treatments, we are leading the way to faster responses, fewer side effects, better outcomes and more hope. At the OSUCCC – James we go beyond the routine to prevent, detect, treat and cure your lung cancer. To learn more, call The James Line at 800-293-5066 or visit cancer.osu.edu.